LYRM4 and non-small cell lung carcinoma: Increased LYRM4 expression promoted malignant phenotypes of non‐small cell lung cancer (NSCLC) cells through modulating ferroptosis, supporting population findings linking rs9606[T] to increased higher NSCLC risk.